A new blood test that screens for levels of a protein called pTau can help you understand your risk for developing Alzheimer’s.
Choose your location, tell us a little about you, and book your appointment.
Complete your quick and easy blood draw. You’ll also receive your compensation of $45 for your time and travel.
A few weeks after your test, a member of our team will share your results, what they mean, and provide you with a copy to share with your doctor.
Hear from others who have participated in clinical research:
“I wholeheartedly hope other people will step up and do it, so they have enough people to fully carry this through.”
Penny
Clinical Study Participant
“I thought this would be a good option for me to get involved with a study that’s going to help people, and with any fortunate of luck, it will help me, too.”
Charles
Clinical Study Participant
“We need people to participate in studies to be able to get these things out there and get them approved.”
Janet
Clinical Study Participant
“I think that people should try to help other islanders by getting this study going, and I think you should do it.”
Mike
Clinical Study Participant
“Research is always important because we want to put these bad illnesses behind us.”
Karen
Clinical Study Participant
“Research is your way to help yourself, your family and all others around to possibly benefit from a life-saving drug or medication down the road that today is not available.”
Olga
Clinical Study Participant
“It’s necessary, and something that we can all do to help move the ball forward…to be involved so that we can be a part of something that’s bigger than ourselves and can help somebody else in the future and maybe help yourself.”
Melissa
Clinical Study Participant
Testimonials provided by trial participants are personal experiences and do not necessarily represent the views of the trial sponsor or Care Access. They are not a substitute for medical advice, and the results of the trial may vary based on individual circumstances. Always consult with your healthcare provider before making any medical decisions.
pTau - A protein that may measure your risk for developing Alzheimer's disease
hsCRP - A high sensitivity protein that, if chronically elevated, can be associated with heart disease risk
A1c - Measures your average blood sugar over the past 2-3 months. It helps diagnose diabetes and prediabetes and monitor long-term blood sugar control.
Creatinine / eGFR - Estimates kidney function by measuring how well your kidneys filter blood. High creatinine or low eGFR may signal kidney disease.
Lp(a) - A genetically determined type of cholesterol that puts you at greater risk of heart disease
Lipid panel - Checks cholesterol and triglyceride levels. High LDL and triglycerides increase the risk of heart disease.
Schedule your blood test and receive:
Screening participants may receive financial compensation for time and travel, including up to $45 upon completion of their first blood test.
Alzheimer's disease is the most common type of dementia. Dementia is a steady decline of memory, thinking, and reasoning skills that impacts a person’s quality of life daily. Memory care techniques are often encouraged by doctors as that can help strengthen cognitive (mental processing) function.
Typically, memory issues and problems finding the right words or getting lost in familiar spaces are common early signs of Alzheimer's disease. Early onset Alzheimer's disease occurs when patients experience symptoms of dementia between the ages of 30 – 60. It’s important to recognize and address any progressive decline in memory or thinking as almost half of patients do not discuss those changes with their doctor.
Alzheimer's disease stages are preclinical, early (mild), moderate (middle), and severe (late). During these stages, symptoms range from being unnoticed to very severe. However, in each stage the brain is affected and changed by the disease. In some cases, early onset Alzheimer's disease occurs when patients experience symptoms of dementia between the ages of 30 – 60.
The cause of Alzheimer's disease is unknown in most cases. However, in cases of early onset Alzheimer's disease, there could be a genetic factor. There are many other factors that could also affect a person’s chance of developing Alzheimer's disease.
Although the cause of Alzheimer’s disease is unknown, for cases of early onset Alzheimer’s disease, there may be a genetic factor for those who have a family history of Alzheimer’s disease. Currently, researchers are learning to measure biomarkers in blood samples. Other genetic factors like Downs syndrome increase the risk of developing Alzheimer’s disease.
Currently, there is no Alzheimer's disease treatment or cure. Certain Alzheimer’s disease treatments are being developed that may help treat symptoms. Memory care techniques are often encouraged by doctors as that can help strengthen cognitive function. Fortunately, new medical research is developing medications to treat early onset Alzheimer's disease hoping to slow the progression of the disease. See if you qualify to participate in a research study today.